International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Non-Functioning Pancreatic Neuroendocrine Tumors-Reference-Cited by-同舟云学术

International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Non-Functioning Pancreatic Neuroendocrine Tumors

Published:2021-07-29 Issue: Volume: Page:
ISSN:0028-3835
Container-title:Neuroendocrinology
language:en
Short-container-title:Neuroendocrinology

Author:

Heidsma Charlotte M.,van Roessel Stijn,van Dieren Susan,Engelsman Anton F.,Strobel Oliver,Buechler Markus W.,Schimmack Simon,Perinel Julie,Adham Mustapha,Deshpande Vikram,Kjaer Josefine,Norlen Olov,Gill Anthony J.,Samra Jaswinder S.,Mittal Anubhav,Hoogwater Frederik J.H.,Primavesi Florian,Stättner Stefan,Besselink Marc G.,van Eijck Casper H.J.,Nieveen van Dijkum E.J.M.

Publisher

S. Karger AG

Subject

Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Reference15 articles.

1. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063–72.

2. Franko J, Feng W, Yip L, Genovese E, Moser AJ. Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2,158 patients. J Gastrointest Surg. 2010;14:541–8.

3. Genç CG, Jilesen AP, Partelli S, Falconi M, Muffatti F, van Kemenade FJ, et al. A new scoring system to predict recurrent disease in grade 1 and 2 nonfunctional pancreatic neuroendocrine tumors. Ann Surg. 2018;267:1148–54.

4. Pulvirenti A, Javed AA, Landoni L, Jamieson NB, Chou JF, Miotto M, et al. Multi-institutional development and external validation of a nomogram to predict recurrence after curative resection of pancreatic neuroendocrine tumors. Ann Surg. 2019. Epub ahead of print.

5. Falconi M, Eriksson B, Kaltsas G, Bartsch DK, Capdevila J, Caplin M, et al. ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology. 2016;103(2):153–71.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ASO Author Reflections: Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors;Annals of Surgical Oncology;2023-12-23

2. Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study;Annals of Surgical Oncology;2023-12-14

3. European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours;Journal of Neuroendocrinology;2023-10-25

4. Clinical Prediction Models for Recurrence in Patients with Resectable Grade 1 and 2 Sporadic Non-Functional Pancreatic Neuroendocrine Tumors: A Systematic Review;Cancers;2023-02-28

5. Chirurgie bei neuroendokrinen Neoplasien des Pankreas: State of the Art;Die Chirurgie;2022-05-02